Asensus Surgical Inc (AMEX: ASXC) on Tuesday, plunged -0.40% from the previous trading day, before settling in for the closing price of $0.25. Within the past 52 weeks, ASXC’s price has moved between $0.20 and $0.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.80%. The company achieved an average annual earnings per share of 38.33%. With a float of $266.67 million, this company’s outstanding shares have now reached $271.99 million.
Let’s determine the extent of company efficiency that accounts for 209 employees.
Asensus Surgical Inc (ASXC) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Asensus Surgical Inc is 1.95%, while institutional ownership is 9.87%. The most recent insider transaction that took place on Dec 14 ’23, was worth 5,078. In this transaction Director of this company bought 18,134 shares at a rate of $0.28, taking the stock ownership to the 39,134 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director sold 18,134 for $0.28, making the entire transaction worth $5,078. This insider now owns 0 shares in total.
Asensus Surgical Inc (ASXC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 38.33% per share during the next fiscal year.
Asensus Surgical Inc (AMEX: ASXC) Trading Performance Indicators
Asensus Surgical Inc (ASXC) is currently performing well based on its current performance indicators. A quick ratio of 2.31 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Asensus Surgical Inc (ASXC)
Looking closely at Asensus Surgical Inc (AMEX: ASXC), its last 5-days average volume was 1.12 million, which is a drop from its year-to-date volume of 1.55 million. As of the previous 9 days, the stock’s Stochastic %D was 5.18%. Additionally, its Average True Range was 0.02.
During the past 100 days, Asensus Surgical Inc’s (ASXC) raw stochastic average was set at 23.82%, which indicates a significant increase from 6.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.43% in the past 14 days, which was lower than the 75.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2768, while its 200-day Moving Average is $0.2967. However, in the short run, Asensus Surgical Inc’s stock first resistance to watch stands at $0.2540. Second resistance stands at $0.2591. The third major resistance level sits at $0.2631. If the price goes on to break the first support level at $0.2449, it is likely to go to the next support level at $0.2409. Now, if the price goes above the second support level, the third support stands at $0.2358.
Asensus Surgical Inc (AMEX: ASXC) Key Stats
Market capitalization of the company is 67.73 million based on 271,986K outstanding shares. Right now, sales total 8,580 K and income totals -78,430 K. The company made 5,430 K in profit during its latest quarter, and -17,230 K in sales during its previous quarter.
